Navigation Links
Glide Pharma Completes Oversubscribed GBP2.7 Million ($4.3 Million) Investment Round
Date:2/10/2010

OXFORD, England, February 10 /PRNewswire/ -- Glide Pharma, a specialty pharmaceutical company focused on the needle-free administration of solid dose therapeutics and vaccines, today announced that it has completed an oversubscribed GBP2.7 million ($4.3 million) investment round. The fundraising was supported by a number of existing institutional and private investors, including Hygea VCT and Oxford Technology VCTs. The company has now completed four successful investment rounds, securing funding totalling approximately GBP10 million. Glide will use the new funds to progress its in-house Glide octreotide programme into clinical development and to continue scale-up of its commercial manufacturing process.

The investment follows the recent successful clinical proof-of-concept of Glide Pharma's proprietary solid dose injector, the Glide SDI(R). The clinical study, conducted in 18 subjects with a solid dose formulation of the analgesic fentanyl, confirmed that the Glide SDI can safely and quickly deliver accurate doses into the systemic circulation, demonstrating the potential of the Glide technology in the $2 billion per annum breakthrough pain market. Throughout the study, administration with the needle-free Glide SDI avoided the bruising and bleeding associated with needle and syringe delivery.

"The completion of this oversubscribed fundraising is a clear demonstration of our investors' confidence in the Glide technology and the advantages it can offer both patients and our partners in the pharmaceutical industry," said Dr Charles Potter, Glide Pharma's CEO. "Glide has made great progress recently, having achieved clinical proof-of-concept with our proprietary solid dose injection system, and ex
'/>"/>

SOURCE Glide Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
2. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
3. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
4. ISTA Pharmaceuticals Announces 2010 Financial Guidance
5. DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv
6. Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010
7. Sagent Pharmaceuticals Announces FDA Approval of Labetalol Hydrochloride Injection, USP
8. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
9. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
10. Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
11. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Increasing requirements, including rising surface ... gaskets indispensable in the chemical and pharmaceutical industries. ... pose major challenges to their performance. Freudenberg-NOK Sealing ... different materials whose scope covers the given requirements ... white FG-360, based on DIN 28091-3, is completely ...
(Date:5/21/2015)... , May 21, 2015  BioClinica®, Inc., ... provider, today announced it has partnered with Kinapse ... clinical trials using BioClinica,s Compass Intelligent Monitoring solution. ... can make a real difference in clinical research," ... excited about this collaboration as it helps move ...
(Date:5/21/2015)...  AbbVie (NYSE: ABBV ) announced today the ... announced offer to acquire each outstanding share of common ... cash and AbbVie common stock, as described in the ... and Exchange Commission by AbbVie on March 23, 2015, ... offer will expire at 5:00 p.m., New ...
Breaking Medicine Technology:Flat gaskets for especially demanding applications in the processing industry 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 2BioClinica and Kinapse Partner to Accelerate Risk-Based Monitoring Implementation 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 2AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 3AbbVie Announces Offer Consideration for Acquisition of Pharmacyclics 4
... The U.S. Food and Drug Administration today approved ... thyroid cancer who are ineligible for surgery and who ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... gland, which is located in the neck. Medullary thyroid ...
... Pure Biomed LLC has launched a full line ... for quick, temporary relief of nerve pain caused by ... damage.  Reunion is the only full line of skin ... Reunion products were developed from the ground up in ...
Cached Medicine Technology:FDA Approves New Treatment for Rare Form of Thyroid Cancer 2FDA Approves New Treatment for Rare Form of Thyroid Cancer 3Affordable Nerve Pain Treatment Now Available in the U.S. 2
(Date:5/21/2015)... Md. (PRWEB) May 21, 2015 The ... the University of Maryland, Baltimore Commercial Advisory Board has ... Maryland Health Care System as one of two $50,000 ... their ankle robot research, known as Anklebot. Developed ... Excellence, in collaboration with the University of Maryland School ...
(Date:5/21/2015)... 21, 2015 Bird B Gone, the leader ... recently added new sizes of the Bird Spike 2001 to ... stainless steel bird spike is specifically designed to reduce ... on roof lines, parapet walls, I-beams, window ledges and more. ... 100 foot boxes, allowing customers to buy the right amount ...
(Date:5/21/2015)... ARBOR, Mich. (PRWEB) May 21, 2015 ... the opposite effect on those with celiac disease according ... More than half of the probiotics tested in the ... in foods and dietary supplements and cause gastrointestinal inflammation ... , Companies aiming to gain consumer trust in gluten-free ...
(Date:5/21/2015)... An existing anti-stroke drug is an effective treatment ... mucus overproduction, improve bacterial clearance and reduce hearing ... and the University of Rochester. , The findings, ... could result in a novel, non-antibiotic treatment for ... drug delivery. Vinpocetine, the drug involved in the ...
(Date:5/21/2015)... 2015 Louis Kraml, CEO of Bingham ... new project and website—CancerTreatmentInfo.org. , With over 40 years ... about how vicious and insidious cancer can be, Mr. ... being treated and cared for. As such, he founded ... safe place where cancer patients, survivors, and family members ...
Breaking Medicine News(10 mins):Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 2Health News:VA Maryland Health Care System Researchers Selected for Abell Foundation Innovation Award 3Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 2Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 3Health News:Public Health Organization NSF International Offers Solution to Gluten in Probiotics, Dietary Supplements 4Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 2Health News:Anti-Stroke Drug Effective Treatment for Middle-Ear Infections, Researchers Say 3Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 2Health News:New Cancer Treatment Website Revolutionizes How Cancer Treatment Information is Being Disseminated 3
... , MORRISTOWN, N.J., July 28 Watson Pharmaceuticals, ... and specialty branded pharmaceuticals, today announced a license agreement with ... generic version of Ferrlecit (sodium ferric gluconate complex in sucrose ... anemia in hemodialysis patients receiving supplemental epoetin therapy. , ...
... pose no great risk to most people; consumer organization aghast ... health authorities on Tuesday placed tighter safety controls on ... and Drug Administration will now categorize the fillings as Class ... risk. Class II devices usually carry some kind of precautions ...
... , , 100% Oxygen Environment ... , SEATTLE, July 28 Northwest Hospital & Medical ... chambers and the launch of hyperbaric oxygen therapy services offered through ... , Hyperbaric oxygen chambers create a 100% oxygen environment, ...
... bypass could be a cause, expert says, , TUESDAY, July ... could be a severe shortage of cardiothoracic surgeons at a ... for surgical procedures that fall under their purview, a new ... of care and delays in care for people needing heart ...
... , , AVON, Conn., July ... its Avon facility,s certification to the international management system standard ... OFS Specialty Photonics Division facilities have maintained ISO 9001 certification ... manufacturing. The Avon facility has taken the additional step ...
... , , WASHINGTON, July 28 ... Action, the legislative lobbying arm of Family Research Council, ... to President Obama,s proposed government takeover of the health care system. ... leaders to discuss the moral, ethical, and financial dangers of President ...
Cached Medicine News:Health News:Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R) 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 2Health News:FDA Calls for Stricter Controls on Mercury Fillings 3Health News:FDA Calls for Stricter Controls on Mercury Fillings 4Health News:Northwest Hospital Introduces Hyperbaric Oxygen Therapy 2Health News:Heart Surgeon Shortage Predicted 2Health News:Heart Surgeon Shortage Predicted 3Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 2Health News:Established Medical Sub-Component Manufacturer Achieves ISO 13485 Certification 3
McPherson curved tying forceps is long has curved shafts with tying platform 4 mm, serrated handle and polished finish. Overall length 110 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Castroviejo tying forceps, straight....
Moria tying forceps are straight, very delicate platforms for 10-0 and 11-0 monofilament. Platforms fully meet to hold suture firmly....
Medicine Products: